GlassScriptPhysician profile
Rajesh Bhola
NPI 1356365001
$23,768.52
in general payments reported to CMS, 2019-2025
32 companies · $1,667 in 2025
The $1,667 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $84.39 · 2021: $7,163 · 2022: $8,273 · 2023: $5,162 · 2024: $1,191 · 2025: $1,667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,472 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,250 · Travel and Lodging: $2,008 · Consulting Fee: $1,290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,472.08 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,250.00 |
| Travel and Lodging | $2,008.12 |
| Consulting Fee | $1,290.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14,053.93 | 2021-2025 | Lifevest |
| Welch Allyn | $3,139.26 | 2021 | |
| Medtronic, INC. | $1,691.92 | 2022-2024 | Venaseal |
| Edwards Lifesciences Corporation | $1,394.78 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $1,062.06 | 2023-2025 | Watchman Access System, General - Brady, Watchman Flx |
| Pfizer INC. | $371.77 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $275.18 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $250.11 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $188.51 | 2021-2023 | Verquvo |
| Heartflow, INC. | $178.20 | 2019-2023 | Ffrct |
| Shockwave Medical, INC | $162.61 | 2022 | |
| Impulse Dynamics (USA) INC. | $128.19 | 2022-2023 | Optimizer |
| Kiniksa Pharmaceuticals, LTD. | $83.19 | 2021-2023 | Arcalyst |
| Medtronic Vascular, INC. | $82.82 | 2019 | |
| Medicomp INC | $75.05 | 2021-2024 | Telepatch Cardiac Monitor |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $67.83 | 2025 | Affinity, Puraply Wound Matrix, Apligraf |
| Sanofi-Aventis U.S. LLC | $63.27 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $61.91 | 2025 | Camzyos |
| Alnylam Pharmaceuticals INC. | $52.68 | 2025 | Amvuttra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.60 | 2022-2023 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $45.42 | 2023 | Inpefa |
| Terumo Medical Corporation | $44.81 | 2024 | Azur Cx Detachable |
| Astrazeneca Pharmaceuticals LP | $42.05 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $38.73 | 2021-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $37.76 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $26.27 | 2024 | |
| Scpharmaceuticals INC. | $20.58 | 2025 | |
| Bard Peripheral Vascular, INC. | $19.90 | 2023 | Venclose Maven Catheter |
| Baxter Healthcare | $16.82 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Itamar Medical INC | $16.78 | 2023 | Watchpatone |
| Kestra Medical Technology Services, INC. | $15.14 | 2022 | |
| Bridgebio Pharma, INC. | $14.39 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Bhola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.